Precision decisions from all‑human 3D models
EXIT Bio accelerates therapeutic development with rapid, reliable screening in advanced human‑relevant models. We help teams de‑risk R&D by bridging the translation gap—delivering actionable data in days, not months.
Platform capabilities
Rapid iteration by design
Plate-based, high-throughput workflows built for efficient screening and decision-making.
All-human biological inputs
Human cells and extracellular matrix to better reflect real tissue microenvironments.
Reproducible, standardized workflows
Integrated quality control and analytics to support consistent, interpretable results.
Translational confidence
All‑human 3D microenvironments to better reflect real tumor biology and reduce late‑stage surprises.
Speed without shortcuts
High‑throughput workflows and standardized analyses deliver ranked readouts quickly and reproducibly.
Fit‑for‑purpose assays
From cytotoxicity and cytokines to imaging and multi‑omic endpoints—configured to your mechanism.
Built by scientists and engineers from academia and industry with a track record in 3D culture, immuno‑oncology, and translational research.